Silvia Hofer

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. ncbi Undifferentiated sarcoma arising in the brain, 23 years after curative treatment of an ependymoma
    Silvia Hofer
    Department of Oncology, , , , 8091, Switzerland
    J Neurooncol 72:239. 2005
  2. ncbi Gefitinib accumulation in glioblastoma tissue
    Silvia Hofer
    Department of Oncology, Zurich University Hospital, Zurich, Switzerland
    Cancer Biol Ther 5:483-4. 2006
  3. ncbi Gefitinib concentrations in human glioblastoma tissue
    Silvia Hofer
    Medical Oncology, , , 8091, , Switzerland
    J Neurooncol 82:175-6. 2007
  4. ncbi Rituximab effective in a patient with refractory autoimmune haemolytic anaemia and CD20-negative multiple myeloma
    Silvia Hofer
    Br J Haematol 122:690-1. 2003
  5. ncbi Spatial heterogeneity of low-grade gliomas at the capillary level: a PET study on tumor blood flow and amino acid uptake
    Matthias T Wyss
    PET Center, Division of Nuclear Medicine, University Hospital, Zurich, Switzerland
    J Nucl Med 48:1047-52. 2007
  6. ncbi Metabolic deactivation of low-grade glioma during chemotherapy
    Ulrich Roelcke
    J Neurol 254:668-9. 2007
  7. ncbi Outcome and prognostic factors in cerebellar glioblastoma multiforme in adults: a retrospective study from the Rare Cancer Network
    Damien C Weber
    University Hospital of Geneva, Geneva, Switzerland
    Int J Radiat Oncol Biol Phys 66:179-86. 2006
  8. ncbi Local targeting of malignant gliomas by the diffusible peptidic vector 1,4,7,10-tetraazacyclododecane-1-glutaric acid-4,7,10-triacetic acid-substance p
    Stefan Kneifel
    Clinic and Institute of Nuclear Medicine, University Hospitals, Basel, Switzerland
    Clin Cancer Res 12:3843-50. 2006
  9. ncbi Avoiding glucocorticoid administration in a neurooncological case
    Hans Peter Rutz
    Division of Radiation Medicine, Paul Scherrer Institut, Switzerland
    Cancer Biol Ther 4:1186-9. 2005
  10. ncbi Delayed-onset and long-lasting severe neutropenia due to rituximab
    Silvia Hofer
    Department of Medical Oncology, St Claraspital, Basel, Switzerland
    Swiss Med Wkly 134:79-80. 2004

Collaborators

  • Hans Peter Rutz
  • Adrian Merlo
  • Hiroshi Nishioka
  • D C Weber
  • St Dirnhofer
  • Brigitta G Baumert
  • Karl Frei
  • Ulrich Roelcke
  • Arnoud Templeton
  • Matthias T Wyss
  • Stefan Kneifel
  • Christian Fretz
  • Silke Gillessen
  • Michael Töpfer
  • Thomas Cerny
  • Andreas Sommacal
  • Matthias Wyss
  • Catrina Uhlmann
  • Valerie Treyer
  • Martin Hefti
  • Esther Bärtschi
  • Mihai C S Ionescu
  • Anthony Ghaffari
  • Beatrice Waser
  • Jean Claude Reubi
  • Stephan Good
  • Martin Kretzschmar
  • Helmut R Maecke
  • Christos Apostolidis
  • Jan Mueller-Brand
  • Dominik Cordier
  • Marlene Arnold
  • Markus Tolnay

Detail Information

Publications11

  1. ncbi Undifferentiated sarcoma arising in the brain, 23 years after curative treatment of an ependymoma
    Silvia Hofer
    Department of Oncology, , , , 8091, Switzerland
    J Neurooncol 72:239. 2005
  2. ncbi Gefitinib accumulation in glioblastoma tissue
    Silvia Hofer
    Department of Oncology, Zurich University Hospital, Zurich, Switzerland
    Cancer Biol Ther 5:483-4. 2006
    ..Our data confirm the capacity of gefitinib to accumulate in solid human tumors in vivo...
  3. ncbi Gefitinib concentrations in human glioblastoma tissue
    Silvia Hofer
    Medical Oncology, , , 8091, , Switzerland
    J Neurooncol 82:175-6. 2007
  4. ncbi Rituximab effective in a patient with refractory autoimmune haemolytic anaemia and CD20-negative multiple myeloma
    Silvia Hofer
    Br J Haematol 122:690-1. 2003
  5. ncbi Spatial heterogeneity of low-grade gliomas at the capillary level: a PET study on tumor blood flow and amino acid uptake
    Matthias T Wyss
    PET Center, Division of Nuclear Medicine, University Hospital, Zurich, Switzerland
    J Nucl Med 48:1047-52. 2007
    ..We used PET with (18)F-fluoro-ethyl-l-tyrosine (FET) to measure the spatial distribution of the amino acid carrier, which is located at the brain capillaries, and (15)O-H(2)O to measure tumor CBF...
  6. ncbi Metabolic deactivation of low-grade glioma during chemotherapy
    Ulrich Roelcke
    J Neurol 254:668-9. 2007
  7. ncbi Outcome and prognostic factors in cerebellar glioblastoma multiforme in adults: a retrospective study from the Rare Cancer Network
    Damien C Weber
    University Hospital of Geneva, Geneva, Switzerland
    Int J Radiat Oncol Biol Phys 66:179-86. 2006
    ..The aim of this study was to assess the outcome in patients with cerebellar glioblastoma (GBM) treated in 15 institutions of the Rare Cancer Network...
  8. ncbi Local targeting of malignant gliomas by the diffusible peptidic vector 1,4,7,10-tetraazacyclododecane-1-glutaric acid-4,7,10-triacetic acid-substance p
    Stefan Kneifel
    Clinic and Institute of Nuclear Medicine, University Hospitals, Basel, Switzerland
    Clin Cancer Res 12:3843-50. 2006
    ..CONCLUSIONS: Targeted radiotherapy using diffusible peptidic vectors represents an innovative strategy for local control of malignant gliomas, which will be further assessed as a neoadjuvant approach...
  9. ncbi Avoiding glucocorticoid administration in a neurooncological case
    Hans Peter Rutz
    Division of Radiation Medicine, Paul Scherrer Institut, Switzerland
    Cancer Biol Ther 4:1186-9. 2005
    ..The role of COX-2 inhibitors in treatment of GBM is detailed, leading to the conclusion of a pressing need for a clinical evaluation of non-steroidal COX-2 inhibitors with the ability to penetrate into brain tumors...
  10. ncbi Delayed-onset and long-lasting severe neutropenia due to rituximab
    Silvia Hofer
    Department of Medical Oncology, St Claraspital, Basel, Switzerland
    Swiss Med Wkly 134:79-80. 2004
    ..The antibody's toxicity is generally mild and transient. There are reports of protracted neutropenia in patients treated with rituximab...
  11. ncbi Extraneural spread of glioblastoma--report of two cases
    Arnoud Templeton
    Medizinische Onkologie, Kantonsspital St Gallen, Schweiz
    Onkologie 31:192-4. 2008
    ..2 years after initial diagnosis she presented with a pleural mass which was a metastasis of the formerly diagnosed glioblastoma. CONCLUSION: Although systemic metastases in glioblastoma are rare, different organs can be involved...